SentimentTrading - Stay updated with the latest stock market news, in-depth financial analysis, and expert investment insights to make smarter decisions.

Sentiment Trading

PLIANT Therapeutics Q2 2026 Results: Strong Oncology Trial, Lower Losses & $160M Cash

PLIANT Therapeutics Q2 2026 Results: Strong Oncology Trial, Lower Losses & $160M Cash

Learn how Pliant Therapeutics’ Phase 1b “FORTIFY” trial advances integrin‑based cancer therapy, cuts R&D costs, and plans 2028 funding strategy.

12/08/2026, 18:28

2 minutes to read

Top News

StepStone Group Q1 2026 Results Set for Aug. 6: Downgrade, Earnings Outlook

StepStone Group Q1 2026 Results Set for Aug. 6: Downgrade, Earnings Outlook

23/07/2026

Invest in NARI Technology: Power‑Grid Automation Set for a 10‑Year Boom

Invest in NARI Technology: Power‑Grid Automation Set for a 10‑Year Boom

11/02/2026

Adecco Group Faces Cybersecurity Scandal Amid Market Resilience and Legal Battle

Adecco Group Faces Cybersecurity Scandal Amid Market Resilience and Legal Battle

16/06/2025

LSRF Surges 20% as China’s New TCM Plan Boosts Traditional Medicine ETF

LSRF Surges 20% as China’s New TCM Plan Boosts Traditional Medicine ETF

13/07/2026

Market Overview

Top Sector News (Pharmaceuticals, Biotechnology & Life Sciences)

Pfizer Q2 2026 Beats Revenue Forecast, Raises 2026 Outlook – Stock Rises

Pfizer Q2 2026 Beats Revenue Forecast, Raises 2026 Outlook – Stock Rises

07/08/2026

Unicycive’s Oxylanthanum Carbonate: Leading the Next Wave of Hyperphosphatemia Therapy

Unicycive’s Oxylanthanum Carbonate: Leading the Next Wave of Hyperphosphatemia Therapy

08/08/2026

Hyperliquid Strategies: Balancing Token Unlocks, Leverage, and RWA Growth to Drive HYPE's Future Value

Hyperliquid Strategies: Balancing Token Unlocks, Leverage, and RWA Growth to Drive HYPE's Future Value

09/08/2026

Beam Therapeutics: Pioneering DNA Base Editing for Genetic Disease Treatment

Beam Therapeutics: Pioneering DNA Base Editing for Genetic Disease Treatment

10/08/2026

All News